Gray zone lymphoma: A case report and comprehensive review of literature.
Uczkowski D, Ashraf H, Cherry M, Dimov N.
Leuk Res Rep. 2023 May 27;19:100372. doi: 10.1016/j.lrr.2023.100372. eCollection 2023.
Neuroanatomy, Gray Matter.
Mercadante AA, Tadi P.
2023 Jul 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Grey matter myelination.
Timmler S, Simons M.
Glia. 2019 Nov;67(11):2063-2070. doi: 10.1002/glia.23614. Epub 2019 Mar 12.
Midbrain circuits for defensive behaviour.
Tovote P, Esposito MS, Botta P, Chaudun F, Fadok JP, Markovic M, Wolff SB, Ramakrishnan C, Fenno L, Deisseroth K, Herry C, Arber S, Lüthi A.
Nature. 2016 Jun 9;534(7606):206-12. doi: 10.1038/nature17996. Epub 2016 Jun 1.
Alteration in topological organization characteristics of gray matter covariance networks in patients with prediabetes.
Deng L, Liu H, Liu W, Liao Y, Liang Q, Wang W.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Oct 28;47(10):1375-1384. doi: 10.11817/j.issn.1672-7347.2022.220085.
MRI-derived brain iron, grey matter volume, and risk of dementia and Parkinson's disease: Observational and genetic analysis in the UK Biobank cohort.
Casanova F, Tian Q, Williamson DS, Qian Y, Zweibaum D, Ding J, Atkins JL, Melzer D, Ferrucci L, Pilling LC.
Neurobiol Dis. 2024 Jul;197:106539. doi: 10.1016/j.nbd.2024.106539. Epub 2024 May 22.
Reimagining the Terms Mongolian Spot and Sign.
Yale S, Tekiner H, Yale ES.
Cureus. 2021 Dec 13;13(12):e20396. doi: 10.7759/cureus.20396. eCollection 2021 Dec.
Voxel-based morphometry and a deep learning model for the diagnosis of early Alzheimer's disease based on cerebral gray matter changes.
Huang H, Zheng S, Yang Z, Wu Y, Li Y, Qiu J, Cheng Y, Lin P, Lin Y, Guan J, Mikulis DJ, Zhou T, Wu R.
Cereb Cortex. 2023 Jan 5;33(3):754-763. doi: 10.1093/cercor/bhac099.
Sleep Dysfunction and Grey Matter Volume.
Paulekiene G, Pajarskiene M, Pajediene E, Radziunas A.
Curr Neurol Neurosci Rep. 2022 Apr;22(4):275-283. doi: 10.1007/s11910-022-01190-x. Epub 2022 Apr 2.
Measurement of Uncertainty in Prediction of No-Reflow Phenomenon after Primary Percutaneous Coronary Intervention Using Systemic Immune Inflammation Index: The Gray Zone Approach.
Ozturk E, Esenboga K, Kurtul A, Kilickap M, Karaagaoglu E, Karakaya J.
Diagnostics (Basel). 2023 Feb 13;13(4):709. doi: 10.3390/diagnostics13040709.
